|
|
|
|
|
|
LVL
Carbon Dioxide-L3K-C (Concentrate)
DCL’s unique L3K technology for enzymatic bicarbonate determination provides reagent stability and performance far beyond what is possible with conventional regenerative systems. This patented technology replaces a very unstable molecule, namely NADH, with a very stable NADH analog molecule.
To improve, we really had to concentrate
DCL is now able to provide this unique chemistry in both a concentrated and nonconcentrated format, enabling vendor consolidation and utilization of identical methodologies across a broad range of chemistry systems including minimum reagent volume chemistry analyzers.The advent of a new level of reagent stability and performance
Discover the synergy produced by combining NADH analogs with the enhanced reagent stabilization capabilities of concentrated reagents. The results are extraordinary. CO2-L3K-C delivers unprecedented 30-day calibration and on-board stability. Interference from hemoglobin, bilirubin and lipemia has virtually been eliminated.
Serum and Plasma specimens
Linearity 1.0-50.0 mEq/L (mmol/L)
Full applications for Roche/Hitachi 717, Olympus AU 640
Suggested Guidelines for Roche/Hitachi 911, Olympus AU 5200
Carbon Dioxide-L3K-C
Single vial, stable liquid, ready-to-use formulation, 14 month shelf life at 2-8°C Cat. No. 288-30 Enzymatic, Rate, 415 nm 2 x 30 mL Cat. No. 288-80 Enzymatic, Rate, 415 nm 1 x 1000 mL Associated Products
Cat. No. SE-035 DC-Cal Calibrator 5 x 3 mL Cat. No. SM-052 DC-Trol Level 1 Control 10 x 5 mL Cat. No. SM-056 DC-Trol Level 2 Control 10 x 5 mL
LLL zvb .g fL
BACK TO CLINICAL CHEMISTRY REAGENTS